Business Consulting

Taylor-Wessing Solicitors.

London, August 2006.
Short-term consultant on drug development and drug safety with regard to patents.
Contact: Edward Vickers.

Valesco Capital.

New York, May 2006.
This was a short term biotech investment analysis and report in May 2006, concerning drug regulatory issues surrounding the safety of a drug that might be released in the United States.
Contact: Dan DiPietro

Electronic Biosciences (EBS).

San Diego, 2004/5.
Consulted at level of Director of Biology between July 2004 and June 2005. I consulted on the overall biological strategy of the company.
Contact: Dr Regina Dugan